Biologically created drugs are the biggest cost for public health plans like B.C. Pharmacare. (Flickr)

B.C. Pharmacare expanding use of ‘biosimilar’ drugs to save money

Europe far ahead of Canada in adopting alternative treatments

Bioengineered drugs for conditions such as diabetes and arthritis are the most expensive part of B.C.’s Pharmacare and other public drug plans, and new alternatives are being introduced.

The shift began Monday with the introduction of a diabetes drug called Jardiance, and a psoriatic arthritis drug called Talz. Coverage is also enhanced for arthritis treatments including certolizumab, leflunomide, rituximab, tocilizumab and tofacitinab.

A list of affected drug treatments can be found here.

The change is expected to save the province $96 million over the first three years, Health Minister Adrian Dix said. B.C. is following the lead of Europe in moving to alternative drugs, replacing patented treatments made from biological sources such as yeasts.

Medical experts say “biosimilars” are genetically as identical as these types of drugs can be. Affected patients in B.C. will be given a six-month transition period with their doctors to introduce the alternative treatments and identify exceptions.

“Biosimilars are a necessary step to ensure Pharmacare coverage provides existing coverage for more people and fund new drugs well into the future,” Dix said.

Cheryl Koehn, president of Arthritis Consumer Experts who has been living with rheumatoid arthritis for decades, said she works with people struggling to get reimbursement for medications recommended by their rheumatologists.

“Today’s announcement is a direct answer to this problem, clinically and financially,” Koehn said. “It ensures continued reimbursement coverage for British Columbians who transition to the next-generation biologic and ensures that reimbursement for other patents becomes available.”

Dr. Tom Elliott, medical director of B.C. Diabetes, said extending coverage for Jardiance for Type 2 diabetes is financed by savings from using insulin glargine biosimilar Basaglar in place of the biologic Lantus.

“This change will entail some inconvenience and require some adaptation for the tens of thousands of British Columbians currently using Lantus and their prescribing physicians,” Elliott said. “Patients and prescribers can rest assured that Basaglar has the same effectiveness and time release pattern, unit for unit, as Lantus.”


@tomfletcherbc
tfletcher@blackpress.ca

Like us on Facebook and follow us on Twitter.

BC legislature

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Minor parties scramble to get candidates nominated for Stikine

Taylor wants to be Christian Heritage Party candidate, Repen makes bid to represent Rural BC Party

Local M.D. urges keeping social bubbles to six

“This situation is happening in our own communities:” Dr. Kate Niethammer

Cullen confirmed as B.C. NDP candidate for Stikine despite party’s equity policy

Former Tahltan Central Government President Annita McPhee said the process made her feel “abused”

Who is or may be running in Stikine in the provincial election

Cullen nomination sparks controversy over NDP equity policy

Citing stability, B.C. Premier calls snap election for Oct. 24

John Horgan meets with Lieutenant Governor to request vote

B.C. reports 91 new cases as officials remain worried over ‘clusters of COVID-19

There have now been a total of 8,395 cases in B.C. since the pandemic began

B.C. Green leader says NDP abandoning environmental plan

Horgan’s claim of unstable government false, Furstenau says

Transgender B.C. brothers debut fantasy novel as author duo Vincent Hunter

‘Transgender people are being misrepresented in popular fiction and media, and we aim to change that’

Is it time to start thinking about greener ways to package cannabis?

Packaging suppliers are still figuring eco-friendly and affordable packaging options that fit the mandates of Cannabis Regulations

‘Won’t be gathering for Thanksgiving:’ Trudeau says COVID-19 2nd wave underway

In all, COVID-19 has killed about 9,250 people in Canada

Join Black Press Media and Do Some Good

Pay it Forward program supports local businesses in their community giving

Canada’s active COVID-19 cases top 10,000 as daily new cases triple over the past month

Dr. Tam repeated her warning to young people, who have made up the majority of recent cases

First 8 months of fatal overdoses in B.C. have now exceeded 2019 death toll

Nine people died every two days in August, BC Coroners Service data shows

Liberal effort to reset policy agenda panned by rivals as too much talk, not action

Trudeau said it’s ‘all too likely’ families won’t be able to gather for Thanksgiving next month

Most Read